Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Parasite researchers win Nobel Prize
Mosquito
"This year’s Nobel Laureates have developed therapies that have revolutionised the treatment of some of the most devastating parasitic diseases” - Nobel assembly.
Awarded for work on malaria and roundworm therapies

The 2015 Nobel Prize in physiology or medicine has been awarded to three researchers for their contributions in developing novel therapies against malaria and roundworm parasite infection.

According to the Guardian, William Campbell and Satoshi Omura were awarded for their work on a therapy against roundworm, shared jointly with Tu Youyou, for a therapy against malaria.

In a statement published by Healio, the Nobel assembly said: "Diseases caused by parasites have plagued humankind for millennia and constitute a major global health problem. In particular, parasitic diseases affect the world’s poorest populations and represent a huge barrier to improving human health and well-being.

"This year’s Nobel Laureates have developed therapies that have revolutionised the treatment of some of the most devastating parasitic diseases.”

Tu discovered the life saving malaria ingredient by extracting the active ingredient of a traditional herbal medicine.

The component, later called artemisinin, targets the parasites during an early stage of their development. It is highly effective in both animals and humans, and is estimated to reduce the number of deaths caused by malaria by over 20 per cent.

Satoshi Omura's research explored the isolation and culture of several new strains of Streptomyces, which are known to have antibacterial qualities.

These were later acquired by William Campbell, who discovered that one of the cultures was effective against parasite infection in animals.  

This led to the discovery of avermectin and its derivative, Mectizan, which has contributed to the global fight against parasitic diseases such as river blindness and onchocerciasis.

Christopher Plowe, president of the American Society of Tropical Medicine and Hygiene, said:  “This year’s Prize recognises scientists who isolated compounds from bacteria and plants and developed them into drugs that have saved countless lives from malaria and prevented millions of cases of blindness and disfiguring swelling from parasitic worms worldwide.

“These three scientists have had a massive positive impact on global health. This was a great choice by the Nobel Committee.”

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.